SARS-CoV-2: An Insight into Detection Tools

(E-pub Ahead of Print)

Author(s): Shaghayegh Khanmohammadi, Mohammadreza Tabary, Farnaz Araghi, Seyed Mohammad Tavangar*

Journal Name: Infectious Disorders - Drug Targets
Formerly Current Drug Targets - Infectious Disorders


Article ID: e160921189885
Become EABM
Become Reviewer
Call for Editor

Abstract:

The novel coronavirus disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), was announced as a pandemic in March 2020. Different diagnostic laboratory tests have been used to detect the infection. Each diagnostic tool, such as Chest Computed tomography (CT) imaging, genome sequencing, nucleic acid amplification methods, whole genome sequencing, microarray, and serology testing have several advantages and disadvantages. Nucleic acid amplification methods are better diagnostic tools for the detection of SARS-CoV-2 in early stages of the infection, while serological tests are more appropriate for the recognition of previously infected patients. In this review, we will briefly consider each diagnostic method, and discuss its pros and cons.

Keywords: COVID-19, SARS-CoV-2, Diagnosis, Polymerase chain reaction, Computed tomography, Serology.

Rights & PermissionsPrintExport Cite as

Article Details

Article ID: e160921189885
Published on: 04 January, 2021
(E-pub Ahead of Print)
DOI: 10.2174/1871526520666210104151849
Price: $95

Article Metrics

PDF: 133